HistoSonics® Developed First-of-its-kind Edison® Histotripsy System

HistoSonics® has developed first-of-its-kind Edison® System. This system stands as the first and only histotripsy platform available in the United States.

The Edison System is designed for the non-invasive eradication of liver tumours, even those that are considered unresectable. It achieves this using a non-thermal, mechanical process centred around focused ultrasound.

The Edison System employs proprietary technology and advanced imaging to administer personalised, precise, and non-invasive histotripsy treatments. This innovative proprietary technology introduces a unique mechanism of action that confers substantial benefits to patients. One such advantage is the ability of the treatment site to undergo a rapid and efficient recovery and reabsorption process.

Histotripsy is a cutting-edge scientific approach that utilises focused sound energy to create controlled acoustic cavitation, leading to the mechanical disintegration and liquefaction of targeted liver tissue, including tumours, at the sub-cellular level.

A unique feature of the platform is its ability to grant physicians continuous, real-time visualisation and control over the destruction of tissue, unlike from any other modality currently in existence.